Henning Boldt, PhD

HenningBoldt
Institution: Mayo Clinic
Category: Investigating how ovarian cancer begins and progresses

Henning Boldt, PhD
Mayo Clinic

The role of pregnancy-associated plasma protein-A (PAPP-A) in ovarian cancer

PAPP-A is a protein that has been shown to reduce tumor incidence and burden. Using a PAPP-A mouse model, Dr. Boldt will examine the development of growth of ovarian cancer and the immune response. The results will provide insight into the role of PAPP-A in ovarian cancer and may indicate it as a potential target for developing therapy.